A recent study at Shriners Hospitals for Children – Cincinnati, one of only four freestanding hospitals in the country dedicated to the treatment of pediatric burns and specializing in plastic and reconstructive surgery, concluded that the Surfacide Helios® UV-C Disinfection System is “…an effective and integral component in reducing bacterial pathogens not killed by the EVS (manual) cleaning process alone.” The findings were published at the American Burn Association's 49th annual meeting in Boston earlier this month. The authors discussed their findings from 234 cultures obtained from rooms and noted a 37 percent organism reduction from terminal cleaning alone. When the Surfacide UV-C Disinfection System was used in addition to the EVS terminal cleaning process, the authors reported a “total elimination of pathogens.”
“Surfacide’s Helios system incorporates three UV-C energy emitting towers in the patient environment to eradicate drug-resistant organisms, including superbugs such as C. Diff, MRSA, VRE, CRE and Acinetobacter,” said Gunner Lyslo, founder and CEO of Surfacide, LLC. “The system has been shown in studies to significantly reduce the risk of HAIs and lower hospital infection rates.”
The 10-to-20 minute Surfacide disinfection cycle is performed in an unoccupied room, after an environmental services cleaning professional has manually cleaned the area and wiped down surfaces. Treating the room with UV-C energy is an evidence-based disinfection modality disinfecting areas that were not completely cleaned manually. Surfacide’s multiple emitter approach disinfects an entire room in just one cycle, including the bathroom and other hard-to-reach areas more quickly and effectively. The Helios emitters are positioned closer to hard surfaces, thereby reducing UV-C disinfection time and improving overall efficacy.
Healthcare providers are turning to UV-C technology as a complement to traditional cleaning methods to combat healthcare-associated infections (HAIs). UV-C energy (at 254nm) is the peak germ-killing part of the ultraviolet spectrum.
Source: Surfacide, LLC
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
From Shortages to Security: How Reusable Health Care Textiles Can Transform Infection Prevention
March 7th 2025Reusable health care textiles enhance infection prevention, reduce waste, and strengthen supply chains. Hygienically clean textiles offer a sustainable, cost-effective alternative to disposable PPE, ensuring patient safety and environmental responsibility.